✦ LIBER ✦

Targeting histone deacetylases in pancreatic ductal adenocarcinoma

✍ Scribed by Günter Schneider; Oliver H. Krämer; Petra Fritsche; Susanne Schüler; Roland M. Schmid; Dieter Saur

Book ID: 114778730
Publisher: Carol Davila University of Medicine Bucharest, Romania
Year: 2009
Tongue: English
Weight: 616 KB
Volume: 14
Category: Article
ISSN: 1582-1838
DOI: 10.1111/j.1582-4934.2009.00974.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epigenetics in sepsis: targeting histone

Epigenetics in sepsis: targeting histone deacetylases

✍ Ciarlo, Eleonora; Savva, Athina; Roger, Thierry 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 760 KB

Targeting ErbB3-mediated stromal–epithel

Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma

✍ Liles, J S; Arnoletti, J P; Kossenkov, A V; Mikhaylina, A; Frost, A R; Kulesza, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 896 KB

Targeting class I histone deacetylases i

Targeting class I histone deacetylases in cancer therapy

✍ Delcuve, Geneviève P; Khan, Dilshad H; Davie, James R 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 522 KB

Dual targeting of mTOR and ErbB pathways

Dual targeting of mTOR and ErbB pathways in pancreatic ductal adenocarcinoma (PDAC)

✍ Broussard, Brett L.; Arnoletti, Juan P.; Mikhaylina, Alevtina; Heslin, Martin J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Targeting Histone Deacetylase in Cancer

Targeting Histone Deacetylase in Cancer Therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer

Targeting histone deacetylase in cancer therapy

✍ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A